Introduction: Increasing evidence suggests that poor lung function in adulthood is
| INTRODUCTION
The lungs mature throughout life, from development of the lung architecture in utero, airway and parenchymal growth in childhood and adolescence, through to degenerative changes during adulthood.
Spirometry is a surrogate measure of both airway calibre and lung growth and the changes in the development of these with age are reflected in lung function testing. 1 Increasing evidence shows that determinants of poor lung function and respiratory disease in adulthood are active in very early life. [2] [3] [4] [5] [6] [7] Both males and females reach their peak lung function in early adulthood, making this an ideal time to assess total lung growth. 1 The
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antenatal, early life and genetic factors that affect this peak in lung function will likely impact on function through to late adulthood.
Reduced lung function in early adulthood is associated with chronic obstructive pulmonary disease (COPD) in later life, 8 emphasizing the importance of attaining maximum lung growth prior to the inevitable decline. Identifying in utero, genetic, and environmental factors which affect growth in lung function from early infancy, throughout childhood and into adulthood, has the potential to lead to interventions that ensure maximum lung growth is attained, thus leading to improved lifelong lung health.
In the Tucson longitudinal respiratory birth cohort study, those with low lung function in infancy continued to have low lung function into adulthood. 9 Despite the importance of this finding, the study's results have not been replicated given the several decades of follow-up necessary and the difficulties in performing infant lung function testing, which was a relatively new technique 30 years ago. 9 In our cohort, infants' lung function was studied very early, at 1 month of age when minimal effect of post-natal exposures would be expected, and was repeated during infancy at 6 and 12 months.
Spirometry was performed by the cohort at follow-up assessments every 6 years between the ages of 6 and 24 years of age. We hypothesized that both lung function at 1 month and post-natal environmental exposures are important in determining the peak lung function reached by young adults. The aims of our study were to: (1) identify the factors associated with lung function measured soon after birth; (2) assess the link between lung function at 1 month of age and lung function in early adulthood; and (3) identify environmental and inherited factors that predict lung function throughout the post-natal growth period, between 1 month and 24 years. 
| MATERIALS AND METHODS

| Statistics
Factors associated with V'maxFRC at 1 month were identified using the General Linear Model. Each potential factor was entered into the model separately. Infant length at time of assessment was included and the mean V'maxFRC for each group was standardized to the mean length of the infants. All significant variables from the univariate model were then included in a multivariate model, including interaction terms.
The association between lung function at 1 month and at subsequent follow-ups was assessed with Pearson's correlation (r) or Spearman's correlation (ρ) for non-parametric variables. R 2 estimated the % variability in spirometry measurements accounted for by infant lung function. V'maxFRC at 1 month was log transformed
(base e) to approach a normal distribution and then adjusted for concurrent length. Dose response slope from histamine challenge was also log transformed. Spirometry variables were adjusted for sex and concurrent height at each assessment.
Linear mixed models were used to assess the link between early life factors and spirometry outcomes longitudinally, in the context of known infant lung function, using unstructured covariance. Spirometry variables from each assessment at 6, 11, 18, and 24 years were included in the model. Time-dependent factors, age and height at each assessment, were included in the model and sex was included as a time-independent factor. Each predictive variable was entered into the model separately and then significant factors were all included in a multivariate model. V'maxFRC was again logarithmically transformed and adjusted for length.
Lung function at 1 month of age as a predictor of recent wheeze and current asthma at each follow-up was assessed with logistic regression and odds ratios are reported. Post-hoc analysis included current atopy as a co-factor in the model, as defined by positive skin prick test. V'maxFRC at 1 month was log transformed, adjusted for length and divided into two groups, about the median. Mean spirometry variables at each assessment were calculated for these two groups, having adjusted for concurrent height, age, and sex and standardized to the mean height and age, using a general linear model. This is portrayed graphically.
A 2-sided P value <0.05 was used to define statistical significance.
Statistical analyses were performed using IBM SPSS Statistics for previously. 24 There was less maternal in utero smoke exposure in the group seen at 18 and 24 years (25%), than in the original cohort (32%).
Unadjusted baseline spirometry at each assessment is presented in Supplementary Table S1 .
| Lung function during infancy
Mean V'maxFRC doubled in the first year of life from 98.9 mL/s (SD 49.6) at 1 month, to 157.2 mL/s (SD 71) at 6 months, and 200.1 mL/s (SD 82.8) at 12 months of age. Lung growth tracked throughout infancy with a strong correlation between V'maxFRC at 1 month and 6 months (ρ = 0.55, P < 0.001) and V'maxFRC at 6 months and 12 months of age (ρ = 0.45, P < 0.001).
| Predictors of lung function at 1 month of age
Male gender was associated with lower lung function at 1 month of age (mean V'maxFRC: males 92.0 mL/s and females 107.3 mL/s, P = 0.019).
Exposure to maternal tobacco smoke in utero was associated with lower infant lung function at 1 month (mean V'maxFRC: 89.4 mL/s if exposed and 104.4 mL/s if not exposed, P = 0.027). Birth weight, parental asthma, paternal smoking during the pregnancy, and infant atopy were not associated with a significant difference in lung function at 1 month of age (Table 1) .
In the multivariate model, sex (P = 0.044), and maternal in utero smoking (P = 0.022) were independently associated with V'maxFRC at 1 month of age. There was no significant interaction effect between sex and maternal smoking on infant lung function (P = 0.576). Table S3 ). Table 2 .
Only variables with a significant relationship in the univariate analysis (P < 0.05) were included in multivariate analysis. V'maxFRC at 1 month was associated with FEF25-75% from 6 to 24 years in the multivariate analysis and infant atopy was associated with FEV 1 , FEF 25-75%, and FEV 1 /FVC from 6 to 24 years (Table 3) .
| Longitudinal lung function and V'maxFRC below and above median
Using Linear Mixed Models, including sex, age, and height in the model, V'maxFRC above the median at 1 month was associated with significantly higher FEF25-75% from 6 to 24 years (mean difference 0.22L/s, P = 0.001) and FEV 1 /FVC longitudinally from 6 to 24 years (mean difference 2.46% P = 0.002). There was no significant association with FEV 1 or FVC. The mean lung function at each assessment are depicted in Figure 1 .
| V'maxFRC predicts wheeze and asthma
Participants with a V'maxFRC below the median at 1 month of age were more likely to have had recent wheeze within the previous 12 months at 6, 11, and 24 years, than those with V'maxFRC above the median.
Participants with a V'maxFRC below the median at 1 month of age were more likely to have asthma in the previous 12 months at 18 and 24 years, than those with V'maxFRC above the median (Table 4 ). These associations remained significant when adjusted for current atopy (OR =4.3, P = 0.013 at 18 years and OR = 5.5, P = 0.009 at 24 years). with variables that reflect airway function. Infant lung function in our cohort was measured in a larger number of subjects and closer to birth with a tightly controlled age range and hence less likely to be influenced by environmental factors. Physiologically, the strength of our current data, when considered alongside data from previous analyses, 9, 18 suggests that a permanent airway structure is laid down in the antenatal period, but that this is separate from the potential for lung growth, which is also known to be influenced by antenatal and early life exposures.
V'maxFRC at 1 month of age was inversely associated with airway responsiveness at 6 and 18 years. That is, those with higher lung function in infancy, had lower airway responsiveness later on and vice versa. Increased airway responsiveness, sensitivity of the airways, is one of the hallmarks of asthma and correlates with symptom severity.
Airway responsiveness is related to inflammation of the lower airways 19 and airway inflammation is associated with reduced airflow. As we did not take airway samples, we could not assess for the presence or degree of airway inflammation. A previous publication from the 6 year followup of the PIAF cohort, showed that increased airway responsiveness during infancy was associated with lower lung function in early childhood. 20 However in subsequent assessments, this association is no longer seen, suggesting that infant airway responsiveness and the presumed underlying inflammation, is not a permanent change.
A number of factors were identified which were associated with lung function at just 1 month of age. Exposure to maternal in utero tobacco smoking and male gender were both independently associated with lower V'maxFRC at 1 month. These findings have previously been reported in the PIAF cohort, albeit when looking at repeated measurements throughout the first year of life, as well as in studies by other groups. 12, 21, 22 We assume that lung function at 1 month of age is reflective of antenatal growth. Only term infants were included and this first assessment was performed before the infants' had any significant respiratory illnesses but there would have been some environmental exposures, such as exposure to tobacco smoke in the home, feeding (breastmilk vs formula) and aeroallergen exposure (house dust mite, animal dander, pollens etc.), which could potentially have had some impact on lung function in the neonatal period.
In utero tobacco smoke exposure was associated with lower infant lung function at 1 month of age as well as lower FEV 1 throughout childhood up to early adulthood. This subtle deficit, mean 77 mL, may be of long-term clinical significance given that a lower FEV 1 in early adulthood is associated with increased risk of COPD as well as all-cause mortality. 23, 24 In this cohort, those with a history of asthma during childhood had persistently lower FEV 1 /FVC throughout childhood up to early adulthood, while a history of maternal asthma was associated with Univariate analysis using linear mixed model. Mean difference in lung function associated with each factor, assessed longitudinally from 6 to 24 years. Time dependent variables age and height at each assessment and the time-independent variable of sex were included in the model. V'maxFRC mL/s at 1 month was log transformed and then adjusted for infant length. Bold font indicates P < 0.05. Multi-variate analysis using linear mixed model. Mean difference in lung function associated with each factor, assessed longitudinally from 6 to 24 years. Time dependent variables age and height at each assessment and the time-independent variable of sex were included in the model. V'maxFRC was log transformed and then adjusted for length. Only variables with P < 0.05 in the univariate model were included in the multivariate model. Bold font indicates P < 0.05.
lower FEV 1 . Asthma in early adulthood is associated with lower infant lung function at 1 month and reduced flow throughout childhood. 25 Low FEV 1 /FVC is a defining criteria of COPD and these results support the hypothesis that childhood asthma is a risk factor for COPD. 26 The association between early atopy and lower lung function from infancy into early adulthood has previously been reported in this cohort. 18, 25 The effect of children smoking tobacco themselves during childhood and adolescence on lung function was not addressed in this study, as parents were present at the assessments up until 18 years of age and thus a truthful answer could not be assumed. Therefore only tobacco smoking at 24 years was included in the model and so we are unable to comment on the effect of self-smoking on the developing lung.
This study has a number of limitations which are inevitable due to the length of follow up. Firstly, the technique for measuring infant lung function which was used in this study is based on the tidal volume range and was the standard in the late 1980s when this study began. This technique has since been adapted to more closely mimic spirometry using raised volume. 27, 28 However, we still found significant correlations between the infant lung function measurement, V'maxFRC, and spirometry variables, particularly FEF25-75%, which is also a measure of airflow at low lung volume. Total infant lung capacity measurements would have been interesting, but measuring this in addition to the technique used would have been impractical. Furthermore, infant lung function testing is a very labor and time intensive procedure, making the recruitment of large cohorts almost impossible. Given that this study has spanned almost 3 decades, a loss to follow up is not unexpected. Perth, Western Australia is a particularly isolated city and many young people travel for work, college, or leisure in their early adult years, which may have contributed to the difficulty in retaining participation. By using mixed models, we were able to compensate for missing values in those who had multiple follow ups.
Another limitation to note is that lung function was performed without bronchodilator responsiveness, therefore reversibility was not assessed. However, in another longitudinal respiratory birth cohort study, there was no significant difference in relationships between pre and post bronchodilator values at follow ups and infant lung function. 9 Lung airflow measurements track from soon after birth into early adulthood, indicating a permanent and stable airway framework, which is laid down in the antenatal period. Lower airway function in infancy is associated with respiratory symptoms through into adulthood, signifying a clinically significant effect. Antenatal factors, particularly tobacco smoke exposure, must continue to be addressed in order to maximize lung function into early adulthood and thus reduce the risk for lifelong respiratory compromise.
